The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
October 2022
Volume 18 Number 9
In coronary interventions, from the SCAAR registry, outcomes of NSTEMI patients pretreated with unfractionated heparin (UFH) before PCI; from the ILIAS Registry, an evaluation of the prognostic value of assessing coronary microvascular dysfunction using coronary flow reserve (CFR) and minimal microvascular resistance (MR) measurements in angina and non-obstructive coronary artery disease. A mini focus on stent thrombosis. In interventions for valvular disease: from the SOLVE-TAVI trial, a comparison of outcomes using different prosthetic valve types in TAVI for patients with left ventricular outflow tract calcification; evaluating bioprosthetic valve dysfunction after TAVI with the LOTUS, mechanically expandable transcatheter valve; and more.